Y Chen, A Lu, Z Hu, J Li, J Lu - Cancer Letters, 2024 - Elsevier
Human epidermal growth factor receptor-3 (ERBB3) is a member of the ERBB receptor tyrosine kinases (RTKs) and is expressed in many malignancies. Along with other ERBB …
SM Groves, GV Ildefonso, CO McAtee, PMM Ozawa… - Cell systems, 2022 - cell.com
Small cell lung cancer (SCLC) tumors comprise heterogeneous mixtures of cell states, categorized into neuroendocrine (NE) and non-neuroendocrine (non-NE) transcriptional …
R Blázquez-Encinas, MT Moreno-Montilla… - Reviews in Endocrine …, 2023 - Springer
Neuroendocrine neoplasms (NENs) comprise a highly heterogeneous group of tumors arising from the diffuse neuroendocrine system. NENs mainly originate in gastrointestinal …
Over half of all people diagnosed with cancer receive radiation therapy. Moderate to severe radiation dermatitis occurs in most human radiation patients, causing pain, aesthetic …
SK Alam, Y Zhang, L Wang, Z Zhu, CE Hernandez… - Oncogene, 2022 - nature.com
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-refractory lung adenocarcinoma (LUAD) progression is a major clinical problem. New approaches to …
SK Alam, L Wang, Y Ren, CE Hernandez… - British journal of …, 2020 - nature.com
Background Small cell lung cancer (SCLC) is the most aggressive form of lung cancer, and new molecular insights are necessary for prognostic and therapeutic advances. Methods …
HS Chang, TC Cheng, SH Tu, CH Wu, YC Liao… - Food Science and …, 2024 - Elsevier
Trastuzumab resistance is one of the causes of poor prognosis in patients with human epidermal growth factor receptor 2 (HER2)-positive (HER2+) breast cancer (BC). The …
LL Wang, XY Wan, TL Wang, CQ Liu, FM Zheng - Medical Oncology, 2022 - Springer
Small cell lung cancer (SCLC) is one of the most malignant types of lung cancer. Cancer stem cell (CSC) and tumor immune evasion are critical for the development of SCLC. We …